Home  ›  Icd 10 Code for Family History of Thyroid Cancer

Icd 10 Code for Family History of Thyroid Cancer

Written By Sunday, March 6, 2022 Add Comment Edit

Thyroid cancer

Last updated

:

January eleven, 2022

Summarytoggle arrow icon

Thyroid cancer is a malignant tumor that arises from either the thyrocytes or the parafollicular cells of the thyroid gland. It is more common in women, especially between 30–50 years of age. The predominant risk factors for thyroid cancer are a history of childhood irradiation to the caput and neck and a family history of thyroid cancer. Thyroid cancer typically manifests as firm to hard thyroid nodule (or nodules). Initial evaluation of all patients includes TSH assay and thyroid ultrasound. Sonographic signs of thyroid cancer include a solid, hypoechoic nodule(s) with irregular margins, microcalcifications, and show of local infiltration into adjacent structures or cervical lymph nodes. On thyroid scintigraphy, which should be obtained in patients with depression serum TSH, a malignant nodule is typically "cold" or hypofunctional. Cytopathological analysis with FNAB is required to ostend the diagnosis. Depending on the jail cell of origin, thyroid cancer tin can be classified as papillary, follicular, medullary, or anaplastic thyroid cancer. Most thyroid cancers are treated surgically with full thyroidectomy (in some cases with hemithyroidectomy), followed by adjuvant therapy, which may include RAIA and TSH suppression therapy with 50-thyroxine, radiation therapy, and chemotherapy. In avant-garde anaplastic carcinoma, only palliative care may be feasible. The prognosis depends on the type of thyroid cancer.

Epidemiological data refers to the US, unless otherwise specified.

Papillary carcinoma is the nigh Prevalent type of thyroid cancer, it features Palpable lymph nodes, and it has the best Prognosis compared to all other types of thyroid cancer.

Thyroid carcinoma may be asymptomatic (eastward.one thousand., thyroid incidentaloma) or manifest with whatever or all of the following clinical features: [x]

  • Thyroid nodule [11] [12]
    • Firm to hard consistency
    • Typically painless
    • Run into too "Ruby flags for thyroid cancer."
  • Features of local infiltration or compression
  • Painless cervical lymphadenopathy [14]
    • More mutual in papillary thyroid cancer and anaplastic thyroid cancer
    • Less common in follicular thyroid cancer
  • Signs of distant metastasis [nineteen]
    • More than common in follicular thyroid cancer and anaplastic thyroid cancer
    • Less common in papillary thyroid cancer
    • Examples include:
      • Pulmonary metastases: coughing, hemoptysis, dyspnea
      • Bone metastases: bone pain, pathologic fractures
      • Brain metastases: focal neurologic deficit, seizures
  • Paraneoplastic syndrome: diarrhea and facial flushing (typically seen in advanced medullary carcinoma) [8]

Laboratory studies and ultrasound

Serum TSH and ultrasound should be obtained in all patients with thyroid nodules.

Thyroid scintigraphy [eleven]

  • Indications
    • Thyroid nodule(south) with ↓ TSH levels
    • Multinodular thyroids (to identify nodules that crave FNAC)
    • Prior to RAIA to evaluate eligibility for adjuvant treatment of well-differentiated thyroid cancer
  • Contraindications: pregnant and breastfeeding women
  • Supportive findings: decreased or no radiotracer uptake (i.e., hypofunctioning or nonfunctioning nodules, referred to as cold nodules) [20]

Nodules that appear hypoechoic on thyroid ultrasound and cold on thyroid scintigraphy should increase suspicion for malignancy.

Hyperfunctioning nodules (hot nodules) are rarely malignant and typically do not crave further evaluation for malignancy. [11] [21]

Confirmatory tests [11] [14]

  • Fine-needle aspiration cytology (FNAC)
    • Indications: sonographic signs of thyroid cancer detected on thyroid ultrasound (see "Indications for FNAC of thyroid nodules")
    • Supportive findings: typically reported every bit "malignant" or "suspicious for malignancy" co-ordinate to the Bethesda system for thyroid cytopathology
  • Intraoperative frozen-department : Consider if FNAC cannot reliably rule out malignancy in high-risk patients.

Thyroid cancer tumor markers

The specific tumor markers depend on the histological type of the cancer.

  • Follicular or papillary thyroid cancer
  • Medullary carcinoma
    • Calcitonin : A hormone secreted by parafollicular cells, which is the tissue of origin of medullary carcinoma
      • Indicated preoperatively if FNAC is suspicious for medullary carcinoma ( supportive diagnostic marking ) [viii] [11])
      • Used to monitor response to therapy
    • Carcinoembryonic antigen (CEA): nonspecific marker, used in combination with calcitonin to monitor response to therapy [8]

Elevation of tumor markers after total thyroidectomy or RAIA indicates persistent affliction, recurrence, or metastasis.

Staging [14]

Staging includes evaluation for cervical lymph node metastases in all patients and of distant metastases as needed.

The differential diagnoses listed here are non exhaustive.

  1. Cancer Stat Facts: Thyroid Cancer. https://seer.cancer.gov/statfacts/html/thyro.html. Updated: Jan 26, 2017. Accessed: January 26, 2017.
  2. Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity.. Future Oncol. 2010; half-dozen (11): p.1771-9. doi: x.2217/fon.x.127 . | Open in Read by QxMD
  3. Veiga LH, Lubin JH, Anderson H, et al. A pooled assay of thyroid cancer incidence post-obit radiotherapy for childhood cancer. Radiat Res. 2012; 178 (4): p.365-376.
  4. Russ G, Leboulleux S, Leenhardt L, Hegedüs 50. Thyroid Incidentalomas: Epidemiology, Risk Stratification with Ultrasound and Workup. Eur Thyroid J. 2014; 3 (3): p.154-163. doi: 10.1159/000365289 . | Open in Read past QxMD
  5. Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for clinical practise for the diagnosis and management of thyroid nodules-2016 update. Endocr Pract. 2016; 22 (5): p.622-39. doi: ten.4158/EP161208.GL . | Open in Read by QxMD
  6. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018; 319 (9): p.914-924. doi: 10.1001/jama.2018.0898 . | Open in Read by QxMD
  7. Popoveniuc G, Jonklaas J. Thyroid nodules.. Med Clin North Am. 2012; 96 (ii): p.329-49. doi: 10.1016/j.mcna.2012.02.002 . | Open in Read past QxMD
  8. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26 (1): p.one-133. doi: 10.1089/thy.2015.0020 . | Open up in Read by QxMD
  9. Donaldson JF, Rodriguez-Gomez IA, Parameswaran R. Rapidly enlarging neck masses of the thyroid with Horner'south syndrome: a concise clinical review. Surgeon. 2015; 13 (2): p.110-5. doi: 10.1016/j.surge.2014.06.010 . | Open in Read by QxMD
  10. Broome JT, Gauger PG, Miller BS, Doherty GM. Anaplastic thyroid cancer manifesting as new-onset Horner syndrome.. Endocr Pract. undefined; 15 (6): p.563-half dozen. doi: ten.4158/EP09106.CRR . | Open in Read by QxMD
  11. Bukhari H, Ayad One thousand, Rosenthal A, Cake M, Cortelli M. Superior vena cava syndrome secondary to thyroid cancer. J Surg Case Rep. 2011; 2011 (7): p.7. doi: 10.1093/jscr/2011.seven.7 . | Open in Read by QxMD
  12. Hyer SL, Dandekar P, Newbold Yard, et al. Thyroid cancer causing obstruction of the great veins in the cervix. World J Surg Oncol. 2008; 6 : p.36. doi: x.1186/1477-7819-half dozen-36 . | Open up in Read by QxMD
  13. Nixon IJ, Whitcher MM, Palmer FL, et al. The Impact of Distant Metastases at Presentation on Prognosis in Patients with Differentiated Carcinoma of the Thyroid Gland. Thyroid. 2012; 22 (9): p.884-889. doi: 10.1089/thy.2011.0535 . | Open in Read by QxMD
  14. Wells SA, Asa SL, Dralle H, et al. Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma. Thyroid. 2015; 25 (half dozen): p.567-610. doi: x.1089/thy.2014.0335 . | Open up in Read by QxMD
  15. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007; 36 (3): p.707-35, vi. doi: 10.1016/j.ecl.2007.04.009 . | Open in Read by QxMD
  16. Mirfakhraee S, Mathews D, Peng 50, Woodruff Southward, Zigman JM. A solitary hyperfunctioning thyroid nodule harboring thyroid carcinoma: review of the literature. Thyroid Res. 2013; 6 (1): p.seven. doi: x.1186/1756-6614-6-7 . | Open in Read by QxMD
  17. King AD. Imaging for staging and management of thyroid cancer. Cancer Imaging. 2008; eight (1): p.57-69. doi: ten.1102/1470-7330.2008.0007 . | Open up in Read by QxMD
  18. Smallridge RC, Ain KB, Asa SL, et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012; 22 (11): p.1104-39. doi: 10.1089/thy.2012.0302 . | Open in Read by QxMD
  19. Batistatou A, Scopa CD. Review manufactures: Pathogenesis and diagnostic significance of nuclear grooves in thyroid and other sites. Int J Surg Pathol. 2008; 17 (2): p.107-110. doi: 10.1177/1066896908316071 . | Open up in Read by QxMD
  20. Patel KN et al. The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults. Ann Surg. 2020; 271 (3): p.e21-e93. doi: x.1097/sla.0000000000003580 . | Open in Read by QxMD
  21. Campos NS, Cardoso LP, Tanios RT, et al. Risk factors for incidental parathyroidectomy during thyroidectomy. Brazilian Periodical of Otorhinolaryngology. 2012; 78 (1): p.57-61. doi: x.1590/s1808-86942012000100009 . | Open in Read by QxMD
  22. Bradly DP, Reddy V, Prinz RA, Gattuso P. Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery. 2009; 146 (6): p.1099-1104. doi: 10.1016/j.surg.2009.09.025 . | Open in Read past QxMD
  23. Nagaiah Thou, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol. 2011 . doi: 10.1155/2011/542358 . | Open in Read by QxMD
  24. Limaiem F, Rehman A, Mazzoni T. Papillary Thyroid Carcinoma. StatPearls. 2021 .
  25. Ashorobi D, Lopez PP. Follicular Thyroid Cancer. StatPearls. 2021 .
  26. Chintakuntlawar AV, Ryder M, Bible KC. Anaplastic Thyroid Cancer and Master Thyroid Lymphoma. Elsevier ; 2021 : p. 246-254.e3
  27. Stamatakos M, Paraskeva P, Stefanaki C, et al. Medullary thyroid carcinoma: The third most mutual thyroid cancer reviewed.. Oncology letters. 2011; ii (i): p.49-53. doi: ten.3892/ol.2010.223 . | Open in Read by QxMD

wallacehoatherand.blogspot.com

Source: https://www.amboss.com/us/knowledge/Thyroid_cancer

0 Response to "Icd 10 Code for Family History of Thyroid Cancer"

Post a Comment

Subscribe to: Post Comments (Atom)

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel